Skip to main content

Table 7 The alterations of methods for anticoagulants or membrane (66 facilities responded)

From: Committee report: Questionnaire survey on the treatment of COVID-19 in patients receiving dialysis therapy

Methods

Number (%)

Nafamostat

6 (9.1)

PMMA membrane

2 (3.0)

Increase in membrane area

2 (3.0)

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us